लिस्डेक्सैम्फेटामाइन
Lisdexamfetamine, sold under the brand names Vyvanse (, ) and Elvanse among others, is a stimulant medication that is used as a treatment for attention deficit hyperactivity disorder (ADHD) in both children and adults, and for moderate-to-severe binge eating disorder in adults. A prodrug of dextroamphetamine, lisdexamfetamine is taken by mouth. Its effects generally begin within 90 minutes and last for up to 14 hours.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 418022579
- Drug.image
- Lisdexamfetamine structure.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 260px
- Drug.image2
- LDX_LISDEXAMFETAMINE_3D-BALL-AND-STICK.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250
- Drug.tradename
- Vyvanse, Elvanse, Tyvense, others
- Drug.MedlinePlus
- a607047
- Drug.DailyMedID
- Lisdexamfetamine
- Drug.pregnancy_AU
Gallery (4)
Connections
Categories
AmphetamineAnorecticsAntihypotensive agentsAphrodisiacsAttention deficit hyperactivity disorder managementChemicals using indexlabelsCodrugsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs acting on the nervous systemDrugs developed by Takeda Pharmaceutical CompanyDrugs with non-standard legal status